share_log

Corvus Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Samlyn Capital, LLC(5.1%),Samlyn, LP(5.1%), etc.

Corvus Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Samlyn Capital, LLC(5.1%),Samlyn, LP(5.1%)等

美股SEC公告 ·  02/14 13:33
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息